Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma) (Q24796737)

1

0 references

A Akesson

2

0 references

P Geborek

3

0 references

M Wildt

4

0 references

C B Wollheim

5

0 references

F A Wollheim

6

0 references

U M Vischer

Arthritis Research and Therapy

7

0 references

language of work or name

English

0 references

publication date

2001

0 references

published in

0 references

volume

3

0 references

issue

3

0 references

page(s)

178-82

0 references

cites work

von Willebrand factor: from cell biology to the clinical management of von Willebrand's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

The effect of ABO blood group on the diagnosis of von Willebrand disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

Raised concentrations of von Willebrand factor antigen in systemic sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

Factor VIII complex in progressive systemic sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

Alterations of fibrinolysis and blood coagulation induced by exercise, and the role of beta-adrenergic-receptor stimulation.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

A sensitive ELISA for von Willebrand factor (vWf:Ag).

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

Noninvasive estimation of systolic pressure in the right ventricle in patients with tricuspid regurgitation.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

Features of endothelial dysfunction in early diabetic nephropathy

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30710

Serum Levels of Aminoterminal Type III Procollagen Peptide and Hyaluronan Predict Mortality in Systemic Sclerosis

28 November 2018

1 reference

12 December 2020

Microalbuminuria and endothelial dysfunction in essential hypertension

1 reference

12 December 2020

Inverse relation between plasma concentration of von Willebrand factor and CrEDTA clearance in systemic sclerosis

1 reference

12 December 2020

Systemic responses in patients with intermittent claudication after treadmill exercise

1 reference

12 December 2020

Endothelial dysfunction precedes development of microalbuminuria in IDDM

1 reference

12 December 2020

Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders.

1 reference

12 December 2020

Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis

1 reference

12 December 2020

von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII)

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon

1 reference

12 December 2020

Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate

1 reference

12 December 2020

The clinical significance of coagulation abnormalities in systemic sclerosis (scleroderma)

1 reference

12 December 2020

Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease

1 reference

12 December 2020

Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma

1 reference

12 December 2020

Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR295

1 reference

3432887

3432887

1 reference

1 reference

1 reference